Primary care and chronicity

Researchers

  • Alba Aguado Jodar

    Primary care and chronicity

  • Ana M Garcia Diaz

    Primary care and chronicity

  • Anna Maria Pedro Pijoan

    Primary care and chronicity

  • Antonia Valsera

    Primary care and chronicity

  • Gemma Ferriz

    Primary care and chronicity

  • Irene Ruiz Tamayo

    Primary care and chronicity

  • Margarita Sellers Career

    Primary care and chronicity

  • Marta Rojas

    Primary care and chronicity

  • Mercè Aliaga

    Primary care and chronicity

  • Monica García Del Alamo

    Primary care and chronicity

  • Natalia Riera Nadal

    Primary care and chronicity

  • Pepi Valverde

    Primary care and chronicity

  • Viviana Liste Salvador

    Primary care and chronicity

Contact the group

Form
  • López-Simarro F, Moral I, Aguado-Jodar A, Cols-Sagarra C, Mancera-Romero J, Alonso-Fernández M, Miravet-Jiménez S, Brotons C. 52/18

    Impact of therapeutic inertia and degree of adherence to treatment on control objectives in people with diabetes.

    Semergen. 2018;44(8):579-585.
  • Sangrós FJ, Torrecilla J, Giráldez-García C, Carrillo L, Mancera J, Mur T, Franch J, Díez J, Goday A, Serrano R, García-Soidán FJ, Cuatrecasas G, Igual D, Moreno A, Millaruelo JM, Carramiñana F, Ruiz MA, Pérez FC, Iriarte Y, Lorenzo Á, González M, Álvarez B, Barutell L, Mayayo MS, Del Castillo M, Navarro E, Malo F, Cambra A, López R, Gutiérrez MÁ, Gutiérrez L, Boente C , Mediavilla JJ, Prieto L, Mendo L, Mansilla MJ, Ortega FJ, Borras A, Sánchez LG, Obaya JC, Alonso M, García F, Gutiérrez ÁT, Hernández AM, Suárez D, Álvarez JC, Sáenz I, Martínez FJ, Casorrán A, Ripoll J, Salanova A, Marín MT, Gutiérrez F, Innerárity J, Álvarez MDM, Artola S, Bedoya MJ, Poveda S, Álvarez F, Brito MJ, Iglesias R, Paniagua F, Nogales P, Gómez Á, Rubio JF, Durán MC, Sagredo J, Gijón MT, Rollán MÁ, Pérez PP, Gamarra J, Carbonell F, García-Giralda L, Antón JJ, de la Flor M, Martínez R, Pardo JL, Ruiz A, Plana R, Macía R, Villaró M, Babace C, Torres JL, Blanco C, Jurado Á, Martín JL, Navarro J, Sanz G, Colas R, Cordero B, de Castro C, Ibáñez M, Monzón A, Porta N, Gómez MDC, Llanes R, Rodríguez JJ , Granero E, Sánchez M, Martínez J, Ezkurra P, Ávila L, de la Sen C, Rodríguez A, Buil P, Gabriel P, Roura P, Tarragó E, Mundet X, Bosch R, González JC, Bobé MI, Mata M , Ruiz I, López F, Birules M, Armengol O, de Miguel RM, Romera L, Benito B, Piulats N, Bilbeny B, Cabré JJ, Cos X, Pujol R, Seguí M, Losada C, de Santiago AM, Muñoz P , Councilor E.

    Association of General and Abdominal Obesity With Hypertension, Dyslipidemia and Prediabetes in the PREDAPS Study.

    Rev Esp Cardiol (Engl Ed). 2018 Mar;71(3):170-177
  • Altes P, Perez P, Esteban C, Sánchez Muñoz-Torrero JF, Aguilar E, García-Díaz AM, Álvarez LR, Jiménez PE, Sahuquillo JC, Monreal M; BRAKE Investigators.

    Raised Fibrinogen Levels and Outcome in Outpatients With Peripheral Artery Disease.

    Angiology. 2018 Jul;69(6):507-512
  • Sangrós FJ, Torrecilla J, Giráldez-García C, Carrillo L, Mancera J, Mur T, Franch J, Díez J, Goday A, Serrano R, García-Soidán FJ, Cuatrecasas G... (Ruiz I). 49/18

    Association of General and Abdominal Obesity With Hypertension, Dyslipidemia and Prediabetes in the PREDAPS Study.

    Rev Esp Cardiol (Engl Ed). 2018;71(3):170-177.
  • Franch-Nadal J, Caballeria L, Mata-Cases M, Mauricio D, Giraldez-García C, Mancera J, Goday A, Mundet-Tudurí X, Regidor E; PREDAPS Study Group. (Ruiz I). 50/18

    Fatty liver index is a predictor of incident diabetes in patients with prediabetes: The PREDAPS study.

    PLoS One. 2018 Jun 1;13(6):e0198327
  • Plaza V, Fernández-Rodríguez C, Melero C, Cosío BG, Entrenas LM, de Llano LP, Gutiérrez-Pereyra F, Tarragona E, Palomino R, López-Viña A; TAI Study Group. (Pedro AM) 1350

    Validation of the 'Test of the Adherence to Inhalers' (TAI) for Asthma and COPD Patients.

    J Aerosol Med Pulm Drug Deliv. 2016 Apr;29(2):142-52.
  • Ruiz-Tamayo I, Franch-Nadal J, Mata-Cases M, Mauricio D, Cos X, Rodriguez-Poncelas A, Barrot J, Coll-de-Tuero G, Mundet-Tudurí X 1313

    Noninsulin Antidiabetic Drugs for Patients with Type 2 Diabetes Mellitus: Are We Respecting Their Contraindications?

    J Diabetes Res. 2016;2016:7502489.
  • Benítez Camps M, Cerain Herrero MJ, de Miguel Lorente N, Martorell Solé E, Flores Mateo G, Pedro Pijoan AM, Murillo-Huapaya C. 1258

    Efficacy and safety of tamsulosin for the conservative treatment of nephritic colic: systematic review with meta-analysis of randomized clinical trials.

    Med Clin (Ship). 2015;145(6):239-47.
  • Rodriguez-Poncelas A, Coll-De Tuero G, Turrò-Garriga O, Barrot-de la Puente J, Franch-Nadal J, Mundet-Tuduri X; RedGDPS Study Group. (Ruiz-Tamayo I) 1220

    Impact of chronic kidney disease on the prevalence of cardiovascular disease in patients with type 2 diabetes in Spain: PERCEDIME2 study.

    BMC Nephrol. 2014 Sep 16;15:150
  • Violán C, Plana-Ripoll O, Foguet-Boreu Q, Bolíbar B, Aguado A, Navarro-Artieda R, Velasco-Velasco S, Sicras-Mainar A; ACG® Study Group. 1141

    Relationship between efficiency and clinical effectiveness indicators in an adjusted model of resource consumption: a cross-sectional study.

    BMC Health Serv Res. 2013:18;13:421.

Projects

    • Year 2018
    • CAP Sagrada Familia

    Study of fragility in patients with Chronic Obstructive Pulmonary Disease. Effectiveness of a combined intervention on frailty and other health outcomes,

    • DISTRICT ATTORNEY:

      Ana Mª Pedro Pijoan

    • TYPE E:

      PINE TREE

  • Primary care and chronicity

    Researcher
    • Year 2017
    • CAP Sagrada Familia

    Networks of multimorbidity, pharmaceutical prescription and risk factors of the Catalan adult population. Study MOrbiNet.

    • DISTRICT ATTORNEY:

      FIS

    • TYPE E:

      PI17/01182

  • Primary care and chronicity

    Researcher
    • Year 2017
    • ABS Sagrada Familia

    Physical exercise and osteoarthritis, don't let osteoarthritis stop you!

    • DISTRICT ATTORNEY:

      Gemma Ferris

    • TYPE E:

      PI

    • Year 2017
    • CAP Sagrada Familia

    Networks of multimorbidity, pharmaceutical prescription and risk factors of the Catalan adult population. Study MOrbiNet.

    • DISTRICT ATTORNEY:

      FIS

    • TYPE E:

      PI17/01182

    • Year 2017
    • ABS Sagrada Familia

    Physical exercise and osteoarthritis, don't let osteoarthritis stop you!

    • DISTRICT ATTORNEY:

      Gemma Ferris

    • TYPE E:

      PINE TREE

  • Primary care and chronicity

    Researcher
    • Year 2016
    • ABS Sagrada Familia

    Networks of multimorbidity, pharmaceutical prescription and risk factors of the Catalan adult population. MorbiNet study,

    • DISTRICT ATTORNEY:

      Alba Aguado

    • TYPE E:

      PI

    • Year 2016
    • ABS Sagrada Familia

    Networks of multimorbidity, pharmaceutical prescription and risk factors of the Catalan adult population. MorbiNet study,

    • DISTRICT ATTORNEY:

      Alba Aguado

    • TYPE E:

      PINE TREE

Lines of action

  • To study chronic conditions, multimorbidity and determinants of diseases
  • To evaluate the effectiveness of educational interventions and drug therapy to achieve a better control of chronic diseases
  • To study activities related to the promotion of healthy lifestyles and their impact on the prevention of diseases
  • To analyze the use and quality of drug therapy

Documents

Information of interest

Links